company background image
A053950 logo

Kyung Nam PharmLtd KOSDAQ:A053950 Stock Report

Last Price

₩769.00

Market Cap

₩54.9b

7D

-8.0%

1Y

-55.8%

Updated

20 Nov, 2024

Data

Company Financials

Kyung Nam Pharm Co.,Ltd.

KOSDAQ:A053950 Stock Report

Market Cap: ₩54.9b

A053950 Stock Overview

Engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia. More details

A053950 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Kyung Nam Pharm Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kyung Nam PharmLtd
Historical stock prices
Current Share Price₩769.00
52 Week High₩2,365.00
52 Week Low₩540.00
Beta0.11
11 Month Change10.97%
3 Month Change-20.88%
1 Year Change-55.78%
33 Year Change-85.49%
5 Year Changen/a
Change since IPO-95.73%

Recent News & Updates

Revenues Not Telling The Story For Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) After Shares Rise 29%

Nov 11
Revenues Not Telling The Story For Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) After Shares Rise 29%

Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected

Aug 19
Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected

Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price

May 21
Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price

Recent updates

Revenues Not Telling The Story For Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) After Shares Rise 29%

Nov 11
Revenues Not Telling The Story For Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) After Shares Rise 29%

Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected

Aug 19
Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected

Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price

May 21
Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price

Does Kyung Nam PharmLtd (KOSDAQ:053950) Have A Healthy Balance Sheet?

Mar 21
Does Kyung Nam PharmLtd (KOSDAQ:053950) Have A Healthy Balance Sheet?

Shareholder Returns

A053950KR PharmaceuticalsKR Market
7D-8.0%-6.3%-0.7%
1Y-55.8%5.5%-4.1%

Return vs Industry: A053950 underperformed the KR Pharmaceuticals industry which returned 5.5% over the past year.

Return vs Market: A053950 underperformed the KR Market which returned -4.1% over the past year.

Price Volatility

Is A053950's price volatile compared to industry and market?
A053950 volatility
A053950 Average Weekly Movement13.4%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.5%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A053950's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A053950's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1993232Oh Hwanwww.kyungnampharm.co.kr

Kyung Nam Pharm Co.,Ltd. engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia. It also offers electronic, and agricultural and livestock products.

Kyung Nam Pharm Co.,Ltd. Fundamentals Summary

How do Kyung Nam PharmLtd's earnings and revenue compare to its market cap?
A053950 fundamental statistics
Market cap₩54.92b
Earnings (TTM)-₩15.91b
Revenue (TTM)₩69.09b

0.8x

P/S Ratio

-3.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A053950 income statement (TTM)
Revenue₩69.09b
Cost of Revenue₩49.77b
Gross Profit₩19.32b
Other Expenses₩35.24b
Earnings-₩15.91b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-225.40
Gross Margin27.97%
Net Profit Margin-23.03%
Debt/Equity Ratio42.2%

How did A053950 perform over the long term?

See historical performance and comparison